Table 1

Baseline and procedure-associated characteristics (n=167)

Age (in years)
≥75 years: 84 (53.2%); ≥78 years: 63 (39.9%)
74.68±8.58
Men102 (61.1%)
CHADS23 (2–4)
CHA2DS2-VASC4 (3–6)
HAS-BLED3 (3–4)
Procedure indication
 Gastrointestinal haemorrhage51 (30.5%)
 Cranial haemorrhage38 (22.8%)
 Other haemorrhages28 (16.8%)
 CVA/embolism with OAC12 (7.2%)
 High risk of bleeding7 (4.2%)
 Others32 (19.2%)
Device size (lobe diameter ranging from 16 to 30)24 (22–25)
Need to change device*6 (3.5%)
Successful implantation158 (94.6%)
Procedural complications9 (5.38%)
 TIA2 (1.2%)
 Vascular complication4 (2.39%)
 Cardiac tamponade2 (1.2%)
 Device migration (percutaneously snared)1 (0.6%)
  • Values expressed as: number (percentage), mean±SD or median (25th–75th percentiles).

  • *Three of the changes were due to a larger size, while the other three to a smaller size.

  • CVA, cerebrovascular accident; HAS-BLED, hypertension, abnormal liver/renal function, stroke history, bleeding predisposition, labile international normalised ratios, elderly, drugs/alcohol use; OAC, oral anticoagulant; TIA, transient ischaemic attack.